Prospective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery
Completed
- Conditions
- Tracheoesophageal FistulaEsophageal AtresiaCongenital Diaphragmatic Hernia
- Interventions
- Procedure: Thoracoscopic surgery
- Registration Number
- NCT02033772
- Lead Sponsor
- Arlyne Thung
- Brief Summary
The study is primarily a descriptive study examining the physiological, ventilatory, surgical, and recovery effects of patients ≤ 6 months of age who undergo thoracoscopic surgery and to determine the accuracy of transcutaneous CO2 (TC-CO2) and end-tidal CO2 (ET-CO2) during high frequency oscillatory ventilation (HFOV) and thoracoscopic procedures.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
- Patients presenting for thoracoscopic surgery
- Patients aged ≤ 6 months of age
Exclusion Criteria
- Patients presenting for any procedure other than thoracoscopic surgery
- Patients aged > 6 months of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Thoracoscopic surgery Thoracoscopic surgery Infants undergoing thoracoscopic surgery.
- Primary Outcome Measures
Name Time Method Change in transcutaneous CO2 Duration of surgery, average of 3 hours.
- Secondary Outcome Measures
Name Time Method Change in blood pressure Duration of surgery, average of 3 hours. Non-invasive and invasive.
Change in ET-CO2 Duration of surgery, average of 3 hours. End-tidal CO2
Change in SpO2 Duration of surgery, average of 3 hours. Oxygen saturation.
Change in heart rate Duration of surgery, average of 3 hours.
Trial Locations
- Locations (1)
Nationwide Children's Hospital
🇺🇸Columbus, Ohio, United States